These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
325 related articles for article (PubMed ID: 30281396)
21. Cognitive Complaints in Survivors of Breast Cancer After Chemotherapy Compared With Age-Matched Controls: An Analysis From a Nationwide, Multicenter, Prospective Longitudinal Study. Janelsins MC; Heckler CE; Peppone LJ; Kamen C; Mustian KM; Mohile SG; Magnuson A; Kleckner IR; Guido JJ; Young KL; Conlin AK; Weiselberg LR; Mitchell JW; Ambrosone CA; Ahles TA; Morrow GR J Clin Oncol; 2017 Feb; 35(5):506-514. PubMed ID: 28029304 [TBL] [Abstract][Full Text] [Related]
22. Cognitive function and discontinuation of adjuvant hormonal therapy in older breast cancer survivors: CALGB 369901 (Alliance). Bluethmann SM; Alfano CM; Clapp JD; Luta G; Small BJ; Hurria A; Cohen HJ; Sugarman S; B Muss H; Isaacs C; Mandelblatt JS Breast Cancer Res Treat; 2017 Oct; 165(3):677-686. PubMed ID: 28653250 [TBL] [Abstract][Full Text] [Related]
23. Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve. Ahles TA; Saykin AJ; McDonald BC; Li Y; Furstenberg CT; Hanscom BS; Mulrooney TJ; Schwartz GN; Kaufman PA J Clin Oncol; 2010 Oct; 28(29):4434-40. PubMed ID: 20837957 [TBL] [Abstract][Full Text] [Related]
24. Genetic Variants Associated with Longitudinal Cognitive Performance in Older Breast Cancer Patients and Controls. Nudelman K; Nho K; Zhang M; McDonald BC; Zhai W; Small BJ; Wegel CE; Jacobsen PB; Jim HSL; Patel SK; Graham DMA; Ahles TA; Root JC; Foroud T; Breen EC; Carroll JE; Mandelblatt JS; Saykin AJ Cancers (Basel); 2023 May; 15(11):. PubMed ID: 37296840 [No Abstract] [Full Text] [Related]
25. Cognitive impairment in older patients with breast cancer before systemic therapy: is there an interaction between cancer and comorbidity? Mandelblatt JS; Stern RA; Luta G; McGuckin M; Clapp JD; Hurria A; Jacobsen PB; Faul LA; Isaacs C; Denduluri N; Gavett B; Traina TA; Johnson P; Silliman RA; Turner RS; Howard D; Van Meter JW; Saykin A; Ahles T J Clin Oncol; 2014 Jun; 32(18):1909-18. PubMed ID: 24841981 [TBL] [Abstract][Full Text] [Related]
26. A scoping review evaluating physical and cognitive functional outcomes in cancer survivors treated with chemotherapy: charting progress since the 2018 NCI think tank on cancer and aging phenotypes. Mohamed M; Ahmed M; Williams AM; Gilmore N; Lin PJ; Yilmaz S; Jensen-Battaglia M; Mustian K; Janelsins M; Mohile S J Cancer Surviv; 2024 Aug; 18(4):1089-1130. PubMed ID: 38743185 [TBL] [Abstract][Full Text] [Related]
27. Non-pharmacological interventions for cognitive impairment due to systemic cancer treatment. Treanor CJ; McMenamin UC; O'Neill RF; Cardwell CR; Clarke MJ; Cantwell M; Donnelly M Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD011325. PubMed ID: 27529826 [TBL] [Abstract][Full Text] [Related]
28. Perceived cognitive impairment in people with colorectal cancer who do and do not receive chemotherapy. Dhillon HM; Tannock IF; Pond GR; Renton C; Rourke SB; Vardy JL J Cancer Surviv; 2018 Apr; 12(2):178-185. PubMed ID: 29080061 [TBL] [Abstract][Full Text] [Related]
29. Physical activity and cognition: longitudinal findings from the Thinking and Living with Cancer Study. Artese AL; Zhou X; Tometich DB; Small BJ; Ahles TA; Ahn J; Bethea TN; Breen EC; Cohen HJ; Extermann M; Graham D; Isaacs C; Jim HSL; McDonald BC; Nakamura ZM; Patel SK; Rentscher KE; Root JC; Saykin AJ; Van Dyk K; Zhai W; Carroll JE; Mandelblatt J J Natl Cancer Inst; 2024 Dec; 116(12):2009-2021. PubMed ID: 39107910 [TBL] [Abstract][Full Text] [Related]
30. Connectivity of the Cerebello-Thalamo-Cortical Pathway in Survivors of Childhood Leukemia Treated With Chemotherapy Only. Phillips NS; Kesler SR; Scoggins MA; Glass JO; Cheung YT; Liu W; Banerjee P; Ogg RJ; Srivastava D; Pui CH; Robison LL; Reddick WE; Hudson MM; Krull KR JAMA Netw Open; 2020 Nov; 3(11):e2025839. PubMed ID: 33216140 [TBL] [Abstract][Full Text] [Related]
31. Cognitive resilience to apolipoprotein E ε4: contributing factors in black and white older adults. Kaup AR; Nettiksimmons J; Harris TB; Sink KM; Satterfield S; Metti AL; Ayonayon HN; Yaffe K; JAMA Neurol; 2015 Mar; 72(3):340-8. PubMed ID: 25599330 [TBL] [Abstract][Full Text] [Related]
32. Personality, coping, and social support as predictors of long-term quality-of-life trajectories in older breast cancer survivors: CALGB protocol 369901 (Alliance). Durá-Ferrandis E; Mandelblatt JS; Clapp J; Luta G; Faul L; Kimmick G; Cohen HJ; Yung RL; Hurria A Psychooncology; 2017 Nov; 26(11):1914-1921. PubMed ID: 28219113 [TBL] [Abstract][Full Text] [Related]
33. Apolipoprotein E and Its Association With Cognitive Change and Modification of Treatment Effects of Vitamin D3 and Omega-3s on Cognitive Change: Results From the In-Clinic Subset of a Randomized Clinical Trial. Vyas CM; Kang JH; Mischoulon D; Cook NR; Reynolds Iii CF; Chang G; Mora S; De Vivo I; Manson JE; Okereke OI J Gerontol A Biol Sci Med Sci; 2024 Mar; 79(3):. PubMed ID: 37952113 [TBL] [Abstract][Full Text] [Related]
34. Association between apolipoprotein E ε4 and longitudinal cognitive decline: nested case-control study among chinese community-dwelling elders. Ma F; Wang J; Miao R; Zhao W; Wang Q Neuropsychobiology; 2011; 64(2):102-9. PubMed ID: 21701228 [TBL] [Abstract][Full Text] [Related]
35. Cognitive Functioning in Survivors of Hematopoietic Stem Cell Transplantation Compared With a Matched General Population Sample-The Maastricht Observational Study of Late Effects After Stem Cell trAnsplantation Study. Wauben B; van der Poel MWM; Greevenbroek MMJ; van Yperen NC; Schram MT; van Boxtel MPJ; Sastry M; Simons SO; Stehouwer CDA; Dagnelie PC; Wesselius A; Schouten HC; Köhler S Transplant Cell Ther; 2023 Jul; 29(7):468.e1-468.e8. PubMed ID: 36966872 [TBL] [Abstract][Full Text] [Related]
36. Vitamin B-12, apolipoprotein E genotype, and cognitive performance in community-living older adults: evidence of a gene-micronutrient interaction. Feng L; Li J; Yap KB; Kua EH; Ng TP Am J Clin Nutr; 2009 Apr; 89(4):1263-8. PubMed ID: 19244370 [TBL] [Abstract][Full Text] [Related]
37. Mirza SS; Saeed U; Knight J; Ramirez J; Stuss DT; Keith J; Nestor SM; Yu D; Swardfager W; Rogaeva E; St George Hyslop P; Black SE; Masellis M; Neurology; 2019 Nov; 93(19):e1807-e1819. PubMed ID: 31575706 [TBL] [Abstract][Full Text] [Related]
38. Impact of taxane-based chemotherapy among older women with breast cancer on cognition and quality of life: a longitudinal pooled analysis. Small BJ; Lange M; Zhai W; Ahn J; Ahles TA; Carroll JE; Cohen HJ; Graham D; Extermann M; Heutte N; Jim HSL; McDonald BC; Patel SK; Root JC; Saykin AJ; Van Dyk K; Zhou X; Mandelblatt J; Joly F; Breast Cancer Res Treat; 2022 Jan; 191(2):459-469. PubMed ID: 34817750 [TBL] [Abstract][Full Text] [Related]
39. Memory complaints and APOE-epsilon4 accelerate cognitive decline in cognitively normal elderly. Dik MG; Jonker C; Comijs HC; Bouter LM; Twisk JW; van Kamp GJ; Deeg DJ Neurology; 2001 Dec; 57(12):2217-22. PubMed ID: 11756600 [TBL] [Abstract][Full Text] [Related]
40. Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy. Koppelmans V; Breteler MM; Boogerd W; Seynaeve C; Gundy C; Schagen SB J Clin Oncol; 2012 Apr; 30(10):1080-6. PubMed ID: 22370315 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]